All News

Community pharmacists help men overcome care avoidance with walk-in screenings, private consults, and outreach.

The major retail entity owns and operates pharmacies across many grocery stores, including Giant, Stop & Shop, Food Lion, and more.

Bryan Wheeler, PharmD, discusses how the Medicare GLP-1 Bridge program works and what it means for independent pharmacy operations.

Direct-to-patient drug programs and telehealth reshape pharmacy, and community pharmacists are an essential component.

Learn about how this functional medicine pharmacist’s personal journey led her to addressing patients’ root causes for disease through exploring gut health dysregulation.

Pharmacists leverage CGM and automated insulin delivery to personalize diabetes care, prevent errors, and expand equitable access to technology.

AAP challenges HHS as ACIP stalls, leaving pharmacists and health care in limbo on vaccine coverage and respiratory recommendations.

Precedence Research announces a report regarding growth in the market size and trends of controlled substances in the US.

Pharmacies boost profits by embedding clinical service alerts into dispensing workflows and improving documentation.

The first generic rifapentine expands affordable treatment for active and latent tuberculosis.

A drug already used to protect the kidneys may now offer a broader shield.

The pharmacy profession is evolving, and for some pharmacists, that evolution is leading them far beyond the prescription counter and into the world of functional medicine.

Retracted vaccine-autism study exposes statistical flaws, reigniting hepatitis B birth-dose debate and highlighting why pharmacists must rely on evidence-based data.

Independent pharmacies boost margins with business insights and smart automation, shifting from dispensing to sustainable growth.

This episode highlights the FDA’s announcement regarding GLP-1 supply stabilization and critical compliance strategies for 503A pharmacies.

Diabetes technology shifts to continuous glucose monitoring, automated insulin delivery, and connected pens, empowering pharmacists to guide safer care.

Artificial intelligence (AI) is making its way into virtually every corner of the health care industry, and pharmacy benefit managers are no exception.

Independent pharmacies can profit from immunizations, boosting loyalty and OTC sales with smart vaccine purchasing and efficient workflows.

In a shifting environment, pharmacy success is no longer just about scale but about earning patient trust through consistency and effectively managing affordability.

Tarah Davis, PharmD, MBA, AFMC, discusses the superpower of personalized patient roadmaps and how identifying drug-induced nutrient depletions is the key to resolving digestive dysfunction.

Pharmacists guide safe OTC allergy choices and compare Allegra, Claritin, and Zyrtec for fast, 24-hour relief from sneezing and itchy eyes.

The FDA approved Foundayo, which is an oral glucagon-like peptide-1 receptor agonist, for weight loss.

Pharmacists help spot nonresponders, navigate accurate testing, and speed diagnosis.

Patient-centered tools like the Patient's Global Impression of Change scale better assess symptoms, function, quality of life, and treatment effectiveness.

FDA advisors back Moderna’s mRNA flu shot for older adults, hinting at a potential egg-free option for 2026–2027.

The ACTIV-6 trial suggests early metformin may halve clinician-diagnosed long COVID risk, offering a low-cost option pharmacists can apply safely.

Pharmacy reimbursement stability is built on transparency, financial visibility, and an understanding of upcoming industry shifts.

Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.